NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
Some of the most popular terms often heard in discussing the Stryker hip recall include “corrosion,” “metal ions” and “metallosis.” As you learn more about the Stryker lawsuits, you may read FDA articles and research studies that frequently use these terms. If you have a Stryker hip implant, you should take care to understand these terms. Those who have Stryker hip implants may be at risk for developing metallosis, which is a type of metal poisoning caused by the release of metal ions into the bloodstream. They may also suffer from corrosion of the Stryker Rejuvenate or ABG II systems, which refers to the wear and tear of the hip implant. Corrosion can cause a person to suffer from extreme pain, swelling, bruising, redness, itching and other uncomfortable conditions.
The U.S. Food and Drug Administration (FDA) has even started reporting on the negative corrosive effects of Stryker hip implants and other metal-on-metal hip devices. After initially approving the Stryker hip systems on June 3, 2008, without extensive clinical safety testing, it seems that the FDA has now reversed its initial decision to approve the product. The FDA later issued warnings about the potential defects in the Stryker hip implants, and these warnings ultimately spurred Stryker Orthopaedics to initiate its own voluntary recall of the Rejuvenate and ABG II systems in April of 2012.